Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosisOA北大核心CSTPCD
Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis
Kaini Shen;Zhuang Tian;Yajuan Gao;Yining Wang;Li Huo;Jian Li;Yun Zhang;Shuyang Zhang
Department of Hematology,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,ChinaDepartment of Cardiology,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,ChinaDepartment of Clinical Medicine,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,ChinaDepartment of Radiology,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,ChinaDepartment of Nuclear Medicine,Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine,State Key Laboratory of Complex Severe and Rare Diseases,Center for Rare Diseases Research,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,ChinaDepartment of Cardiology,The Key Laboratory of Cardiovascular Remodeling and Function Research,Chinese Ministry of Education,Chinese National Health Commission and Chinese Academy of Medical Sciences,The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine,Qilu Hospital,Cheeloo College of Medicine,Shandong University,Jinan,Shandong 250012,China||Cardiovascular Disease Research Center of Shandong First Medical University,Central Hospital Affiliated to Shandong First Medical University,Jinan,Shandong 250013,China
《中华医学杂志（英文版）》 2024 (002)
127-129 / 3
This research was supported by grants from the CAMS Innovation Fund for Medical Sciences(No.CIFMS 2021-I2M-1-003),National High Level Hospital Clinical Research Funding(No.2022-PUMCH-B-098),and the National Key Research and Development Program of China(No.2022YFC2703100).
评论